Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Pandemics and Biosecurity
3OCT

WHO calls Uganda's Ebola outbreak over

2 min read
13:42UTC

WHO declared Uganda's Bundibugyo Ebola outbreak over on 26 August, closing a 20-case, two-death chain a month after Kampala called it finished.

ScienceDeveloping
Key takeaway

WHO confirmed Uganda's 20-case Ebola chain had ended, a month after Kampala declared it.

The World Health Organization (WHO) declared Uganda's Bundibugyo Ebola outbreak over on 26 August, closing a chain of 20 cases and two deaths⁠1. WHO waits 42 days, twice Ebola's longest incubation period, before calling an outbreak over. Uganda's count started when Mulago National Referral Hospital in Kampala discharged the country's last patient on 16 July.

The Ugandan government had declared itself Ebola-free on 28 July, a month before WHO's countdown ended. WHO's declaration confirms that call rather than overturning it. The two countries share a long border, and DR Congo, where the outbreak began, has recorded thousands of cases since May.

Deep Analysis

In plain English

Ebola reached Uganda from neighbouring DR Congo earlier this year. Uganda confirmed 20 infections and two deaths. To be sure an outbreak is over, WHO waits 42 days after the last patient recovers or dies. That is twice the longest time the virus can hide in a body before causing symptoms. Uganda's government announced the end early, in July. WHO made it official on 26 August. Uganda now wants other countries to drop the travel restrictions they put on it, though the outbreak next door in DR Congo is still growing.

Deep Analysis
Root Causes

Uganda's outbreak stayed at 20 cases because each chain was imported from DR Congo, not seeded locally. All 20 cases trace back to DR Congo, so tracers knew where to look.

Uganda has built Ebola response capacity across several outbreaks since 2000, including the original 2007 Bundibugyo outbreak, and keeps standing district teams. It also closed its shared border with DR Congo to non-essential travel and helped set up two mobile laboratories inside DR Congo .

Reintroduction from DR Congo stays likely. Uganda shares a long border with Ituri and North Kivu, and trade and refugee movement across it never fully stops.

What could happen next?
  • Consequence

    Countries that restricted travel from Uganda now face pressure to lift those rules, while keeping them for DR Congo.

  • Risk

    A new import from North Kivu would restart Uganda's 42-day count.

First Reported In

Update #14 · River boat carries Ebola 1,000 km downriver

Al Jazeera· 3 Oct 2026
Read original →
Different Perspectives
IGWG co-chair Tovar da Silva Nunes
IGWG co-chair Tovar da Silva Nunes
The Brazilian co-chair closed the eighth pathogen-sharing session on 18 September without an agreed annex text, the second session in a row to end that way. He presented the outcome as continued commitment, with adoption due at the World Health Assembly in May 2027.
Fraport
Fraport
The Frankfurt Airport operator has told staff to watch for fever, hessenschau reported, after six airport workers caught malaria. Germany does not require insecticide spraying of arriving aircraft cabins, and parasite genotyping to trace the source is due at the end of October.
European Centre for Disease Prevention and Control
European Centre for Disease Prevention and Control
ECDC reported the eight Frankfurt Airport malaria cases on 18 September and considers repeated arrivals of infected mosquitoes on aircraft likely. It has not ruled out local mosquitoes, and awaits genotyping due at the end of October.
Pan American Health Organization
Pan American Health Organization
PAHO counted 53,957 measles cases in the Americas by 19 September and is supporting Peru's response in Puno and Arequipa. It warns that October's Señor de los Milagros festivities and Pope Leo XIV's November visit could increase transmission.
Bangladesh Directorate General of Health Services
Bangladesh Directorate General of Health Services
The DGHS recorded 1,030 measles-related deaths and 172,720 suspected cases by 14 September, after a campaign that reached 19.75 million children. Its disease-control director, Halimur Rashid, said further vaccination rounds were expected within two weeks.
Minapharm
Minapharm
The Egyptian drugmaker and its Berlin subsidiary ProBioGen were awarded up to US$16.5m by CEPI on 27 August to take a Bundibugyo vaccine into a Phase 1 trial in Africa. Final manufacture is planned for Cairo, making it CEPI's first Bundibugyo candidate with an African producer.